BRINP1 Polyclonal Antibody, RBITC Conjugated
Product Specifications
Background
Inhibits cell proliferation by negative regulation of the G1/S transition. Mediates cell death which is not of the classical apoptotic type and regulates expression of components of the plasminogen pathway.
Synonyms
DBC1; FAM5A; DBCCR1; BMP/retinoic acid-inducible neural-specific protein 1; Deleted in bladder cancer protein 1; BRINP1; IB3089A
Gene ID
1620
Swiss Prot
O60477
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
101-200/761
Target
BRINP1
Clonality
Polyclonal
Isotype
IgG
Conjugation
RBITC
Source
Synthetic peptide from human DBC1 conjugated to KLH
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1620
Predicted Cross Reactivity
Cow, Pig, Horse, Chicken, Rabbit
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
